際際滷shows by User: singh_br1762 / http://www.slideshare.net/images/logo.gif 際際滷shows by User: singh_br1762 / Fri, 20 Jun 2025 00:17:33 GMT 際際滷Share feed for 際際滷shows by User: singh_br1762 Yoga Postures to Practice鐃for Holistic (Physical, Mental, and Cognitive) Well-being /slideshow/yoga-postures-to-practice-for-holistic-physical-mental-and-cognitive-well-being/280781630 yogaforforhealth-250620001734-24c66535
An ancient System for holistic health (mental and physical) and wellbeing, is a scientific art of living with harmony (connecting) of mind and body. Although much more ancient than Patanjali, who documented yoga systematically about 2000 years ago, Patanjali is often referred to as the "father of modern yoga." Yoga postures are commonly depicted in ancient paintings, carvings, and sculptures in almost all civilizations and religions, thus Yoga cant be described as an act of Hinduism. It originated long before any religion on Earth, with the emergence of life on the Planet. All yoga poses are natural, and what is not natural is not yoga; it isViyoga. Besides Vedic Yoga, Hatha, Vinyasa, Ashtanga, Iyengar, Yin, Restorative, Kundalini, Bikram, Sahaj, and Power yoga are some popular types. VinyasaYoga is the closest form to Vedic Yoga; it is known for its flowing movements, not very rigorous, not too much straining, actions flow with the breath. Though all yoga may lead to meditation (Dhyan) for your inner upliftment, it is not the same as described in Hinduism for self-liberation. In Hinduism, different paths of life looking distinct but can be practiced all together, they are: Karma Yoga (selfless action and service), Bhakti Yoga (devotion and love for God or Godly power), Jnana (Gyan) Yoga (gaining knowledge for self-realization through wisdom), Dhyan Yoga (meditation) and Kriya Yoga (optimum utilization of your vital and muscular energy). ]]>

An ancient System for holistic health (mental and physical) and wellbeing, is a scientific art of living with harmony (connecting) of mind and body. Although much more ancient than Patanjali, who documented yoga systematically about 2000 years ago, Patanjali is often referred to as the "father of modern yoga." Yoga postures are commonly depicted in ancient paintings, carvings, and sculptures in almost all civilizations and religions, thus Yoga cant be described as an act of Hinduism. It originated long before any religion on Earth, with the emergence of life on the Planet. All yoga poses are natural, and what is not natural is not yoga; it isViyoga. Besides Vedic Yoga, Hatha, Vinyasa, Ashtanga, Iyengar, Yin, Restorative, Kundalini, Bikram, Sahaj, and Power yoga are some popular types. VinyasaYoga is the closest form to Vedic Yoga; it is known for its flowing movements, not very rigorous, not too much straining, actions flow with the breath. Though all yoga may lead to meditation (Dhyan) for your inner upliftment, it is not the same as described in Hinduism for self-liberation. In Hinduism, different paths of life looking distinct but can be practiced all together, they are: Karma Yoga (selfless action and service), Bhakti Yoga (devotion and love for God or Godly power), Jnana (Gyan) Yoga (gaining knowledge for self-realization through wisdom), Dhyan Yoga (meditation) and Kriya Yoga (optimum utilization of your vital and muscular energy). ]]>
Fri, 20 Jun 2025 00:17:33 GMT /slideshow/yoga-postures-to-practice-for-holistic-physical-mental-and-cognitive-well-being/280781630 singh_br1762@slideshare.net(singh_br1762) Yoga Postures to Practice鐃for Holistic (Physical, Mental, and Cognitive) Well-being singh_br1762 An ancient System for holistic health (mental and physical) and wellbeing, is a scientific art of living with harmony (connecting) of mind and body. Although much more ancient than Patanjali, who documented yoga systematically about 2000 years ago, Patanjali is often referred to as the "father of modern yoga." Yoga postures are commonly depicted in ancient paintings, carvings, and sculptures in almost all civilizations and religions, thus Yoga cant be described as an act of Hinduism. It originated long before any religion on Earth, with the emergence of life on the Planet. All yoga poses are natural, and what is not natural is not yoga; it isViyoga. Besides Vedic Yoga, Hatha, Vinyasa, Ashtanga, Iyengar, Yin, Restorative, Kundalini, Bikram, Sahaj, and Power yoga are some popular types. VinyasaYoga is the closest form to Vedic Yoga; it is known for its flowing movements, not very rigorous, not too much straining, actions flow with the breath. Though all yoga may lead to meditation (Dhyan) for your inner upliftment, it is not the same as described in Hinduism for self-liberation. In Hinduism, different paths of life looking distinct but can be practiced all together, they are: Karma Yoga (selfless action and service), Bhakti Yoga (devotion and love for God or Godly power), Jnana (Gyan) Yoga (gaining knowledge for self-realization through wisdom), Dhyan Yoga (meditation) and Kriya Yoga (optimum utilization of your vital and muscular energy). <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/yogaforforhealth-250620001734-24c66535-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> An ancient System for holistic health (mental and physical) and wellbeing, is a scientific art of living with harmony (connecting) of mind and body. Although much more ancient than Patanjali, who documented yoga systematically about 2000 years ago, Patanjali is often referred to as the &quot;father of modern yoga.&quot; Yoga postures are commonly depicted in ancient paintings, carvings, and sculptures in almost all civilizations and religions, thus Yoga cant be described as an act of Hinduism. It originated long before any religion on Earth, with the emergence of life on the Planet. All yoga poses are natural, and what is not natural is not yoga; it isViyoga. Besides Vedic Yoga, Hatha, Vinyasa, Ashtanga, Iyengar, Yin, Restorative, Kundalini, Bikram, Sahaj, and Power yoga are some popular types. VinyasaYoga is the closest form to Vedic Yoga; it is known for its flowing movements, not very rigorous, not too much straining, actions flow with the breath. Though all yoga may lead to meditation (Dhyan) for your inner upliftment, it is not the same as described in Hinduism for self-liberation. In Hinduism, different paths of life looking distinct but can be practiced all together, they are: Karma Yoga (selfless action and service), Bhakti Yoga (devotion and love for God or Godly power), Jnana (Gyan) Yoga (gaining knowledge for self-realization through wisdom), Dhyan Yoga (meditation) and Kriya Yoga (optimum utilization of your vital and muscular energy).
Yoga Postures to Practice for Holistic (Physical, Mental, and Cognitive) Well-being from Bhoj Raj Singh
]]>
43 0 https://cdn.slidesharecdn.com/ss_thumbnails/yogaforforhealth-250620001734-24c66535-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Classification of Microbes: Purposes and Uses /slideshow/classification-of-microbes-purposes-and-uses/275863977 classificationofmicrobes-250220184536-029c5e5b
Briefly describe different ways to classify microbes. Classification is helpful to understand their physiochemical and pathological characteristics and to identify microbes.]]>

Briefly describe different ways to classify microbes. Classification is helpful to understand their physiochemical and pathological characteristics and to identify microbes.]]>
Thu, 20 Feb 2025 18:45:36 GMT /slideshow/classification-of-microbes-purposes-and-uses/275863977 singh_br1762@slideshare.net(singh_br1762) Classification of Microbes: Purposes and Uses singh_br1762 Briefly describe different ways to classify microbes. Classification is helpful to understand their physiochemical and pathological characteristics and to identify microbes. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/classificationofmicrobes-250220184536-029c5e5b-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Briefly describe different ways to classify microbes. Classification is helpful to understand their physiochemical and pathological characteristics and to identify microbes.
Classification of Microbes: Purposes and Uses from Bhoj Raj Singh
]]>
431 0 https://cdn.slidesharecdn.com/ss_thumbnails/classificationofmicrobes-250220184536-029c5e5b-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
A comparative study on uroculturome antimicrobial susceptibility in apparently healthy and urinary tract infected humans.pptx /slideshow/a-comparative-study-on-uroculturome-antimicrobial-susceptibility-in-apparently-healthy-and-urinary-tract-infected-humans-pptx/269987018 acomparativestudyonuroculturomeantimicrobialsusceptibilityinapparentlyhealthyandurinarytractinfected-240701045021-f89bd9ae
The uroculturome indicates the profile of culturable microbes inhabiting the urinary tract, and it is often required to do a urine culture to find an effective antimicrobial to treat UTIs. This study targeted to understand the profile of culturable pathogens in the urine of apparently healthy (128) and humans with clinical UTIs (161). In urine samples from UTI cases, microbial counts were 1.2104 賊 6.02103 colony-forming units (cfu)/ mL, while in urine samples from apparently healthy humans, the average count was 3.33賊 1.34103 cfu/ mL. In eight samples (six from UTI cases and two from apparently healthy people) of urine, Candida (C. albicans 3, C. catenulata 1, C. krusei 1, C. tropicalis 1, C. parapsiplosis 1, C. gulliermondii 1) and Rhizopus species (1) were detected. Candida krusei was detected only in a single urine sample from a healthy person and C. albicans was detected both in urine of healthy and clinical UTI cases. Fungal strains were always detected with one or more types of bacteria. Gram-positive bacteria were more commonly (OR, 1.98; CI99, 1.01-3.87) detected in urine samples of apparently healthy humans, and Gram -ve bacteria (OR, 2.74; CI99, 1.44-5.23) in urines of UTI cases. From urine samples of 161 UTI cases, a total of 90 different types of microbes were detected and, 73 samples had only a single type of bacteria. In contrast, 49, 29, 3, 4, 1, and 2 samples had 2, 3, 4, 5, 6 and 7 types of bacteria, respectively. The most common bacteria detected in urine of UTI cases was Escherichia coli detected in 52 samples, in 20 cases as the single type of bacteria, other 34 types of bacteria were detected in pure form in 53 cases. From 128 urine samples of apparently healthy people, 88 types of microbes were detected either singly or in association with others, from 64 urine samples only a single type of bacteria was detected while 34, 13, 3, 11, 2 and 1 samples yielded 2, 3, 4, 5, 6 and seven types of microbes, respectively. In the urine of apparently healthy humans too, E. coli was the most common bacteria, detected in pure culture from 10 samples followed by Staphylococcus haemolyticus (9), S. intermedius (5), and S. aureus (5), and similar types of bacteria also dominated in cases of mixed occurrence, E. coli was detected in 26, S. aureus in 22 and S. haemolyticus in 19 urine samples, respectively. Gram +ve bacteria isolated from urine samples' irrespective of health status were more often (p, <0.01) resistant than Gram -ve bacteria to ajowan oil, holy basil oil, cinnamaldehyde, and cinnamon oil, but more susceptible to sandalwood oil (p, <0.01). However, for antibiotics, Gram +ve were more often susceptible than Gram -ve bacteria to cephalosporins, doxycycline, and nitrofurantoin. The study concludes that to understand the role of good and bad bacteria in the urinary tract microbiome more targeted studies are needed to discern the isolates at the pathotype level.]]>

The uroculturome indicates the profile of culturable microbes inhabiting the urinary tract, and it is often required to do a urine culture to find an effective antimicrobial to treat UTIs. This study targeted to understand the profile of culturable pathogens in the urine of apparently healthy (128) and humans with clinical UTIs (161). In urine samples from UTI cases, microbial counts were 1.2104 賊 6.02103 colony-forming units (cfu)/ mL, while in urine samples from apparently healthy humans, the average count was 3.33賊 1.34103 cfu/ mL. In eight samples (six from UTI cases and two from apparently healthy people) of urine, Candida (C. albicans 3, C. catenulata 1, C. krusei 1, C. tropicalis 1, C. parapsiplosis 1, C. gulliermondii 1) and Rhizopus species (1) were detected. Candida krusei was detected only in a single urine sample from a healthy person and C. albicans was detected both in urine of healthy and clinical UTI cases. Fungal strains were always detected with one or more types of bacteria. Gram-positive bacteria were more commonly (OR, 1.98; CI99, 1.01-3.87) detected in urine samples of apparently healthy humans, and Gram -ve bacteria (OR, 2.74; CI99, 1.44-5.23) in urines of UTI cases. From urine samples of 161 UTI cases, a total of 90 different types of microbes were detected and, 73 samples had only a single type of bacteria. In contrast, 49, 29, 3, 4, 1, and 2 samples had 2, 3, 4, 5, 6 and 7 types of bacteria, respectively. The most common bacteria detected in urine of UTI cases was Escherichia coli detected in 52 samples, in 20 cases as the single type of bacteria, other 34 types of bacteria were detected in pure form in 53 cases. From 128 urine samples of apparently healthy people, 88 types of microbes were detected either singly or in association with others, from 64 urine samples only a single type of bacteria was detected while 34, 13, 3, 11, 2 and 1 samples yielded 2, 3, 4, 5, 6 and seven types of microbes, respectively. In the urine of apparently healthy humans too, E. coli was the most common bacteria, detected in pure culture from 10 samples followed by Staphylococcus haemolyticus (9), S. intermedius (5), and S. aureus (5), and similar types of bacteria also dominated in cases of mixed occurrence, E. coli was detected in 26, S. aureus in 22 and S. haemolyticus in 19 urine samples, respectively. Gram +ve bacteria isolated from urine samples' irrespective of health status were more often (p, <0.01) resistant than Gram -ve bacteria to ajowan oil, holy basil oil, cinnamaldehyde, and cinnamon oil, but more susceptible to sandalwood oil (p, <0.01). However, for antibiotics, Gram +ve were more often susceptible than Gram -ve bacteria to cephalosporins, doxycycline, and nitrofurantoin. The study concludes that to understand the role of good and bad bacteria in the urinary tract microbiome more targeted studies are needed to discern the isolates at the pathotype level.]]>
Mon, 01 Jul 2024 04:50:20 GMT /slideshow/a-comparative-study-on-uroculturome-antimicrobial-susceptibility-in-apparently-healthy-and-urinary-tract-infected-humans-pptx/269987018 singh_br1762@slideshare.net(singh_br1762) A comparative study on uroculturome antimicrobial susceptibility in apparently healthy and urinary tract infected humans.pptx singh_br1762 The uroculturome indicates the profile of culturable microbes inhabiting the urinary tract, and it is often required to do a urine culture to find an effective antimicrobial to treat UTIs. This study targeted to understand the profile of culturable pathogens in the urine of apparently healthy (128) and humans with clinical UTIs (161). In urine samples from UTI cases, microbial counts were 1.2104 賊 6.02103 colony-forming units (cfu)/ mL, while in urine samples from apparently healthy humans, the average count was 3.33賊 1.34103 cfu/ mL. In eight samples (six from UTI cases and two from apparently healthy people) of urine, Candida (C. albicans 3, C. catenulata 1, C. krusei 1, C. tropicalis 1, C. parapsiplosis 1, C. gulliermondii 1) and Rhizopus species (1) were detected. Candida krusei was detected only in a single urine sample from a healthy person and C. albicans was detected both in urine of healthy and clinical UTI cases. Fungal strains were always detected with one or more types of bacteria. Gram-positive bacteria were more commonly (OR, 1.98; CI99, 1.01-3.87) detected in urine samples of apparently healthy humans, and Gram -ve bacteria (OR, 2.74; CI99, 1.44-5.23) in urines of UTI cases. From urine samples of 161 UTI cases, a total of 90 different types of microbes were detected and, 73 samples had only a single type of bacteria. In contrast, 49, 29, 3, 4, 1, and 2 samples had 2, 3, 4, 5, 6 and 7 types of bacteria, respectively. The most common bacteria detected in urine of UTI cases was Escherichia coli detected in 52 samples, in 20 cases as the single type of bacteria, other 34 types of bacteria were detected in pure form in 53 cases. From 128 urine samples of apparently healthy people, 88 types of microbes were detected either singly or in association with others, from 64 urine samples only a single type of bacteria was detected while 34, 13, 3, 11, 2 and 1 samples yielded 2, 3, 4, 5, 6 and seven types of microbes, respectively. In the urine of apparently healthy humans too, E. coli was the most common bacteria, detected in pure culture from 10 samples followed by Staphylococcus haemolyticus (9), S. intermedius (5), and S. aureus (5), and similar types of bacteria also dominated in cases of mixed occurrence, E. coli was detected in 26, S. aureus in 22 and S. haemolyticus in 19 urine samples, respectively. Gram +ve bacteria isolated from urine samples' irrespective of health status were more often (p, <0.01) resistant than Gram -ve bacteria to ajowan oil, holy basil oil, cinnamaldehyde, and cinnamon oil, but more susceptible to sandalwood oil (p, <0.01). However, for antibiotics, Gram +ve were more often susceptible than Gram -ve bacteria to cephalosporins, doxycycline, and nitrofurantoin. The study concludes that to understand the role of good and bad bacteria in the urinary tract microbiome more targeted studies are needed to discern the isolates at the pathotype level. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/acomparativestudyonuroculturomeantimicrobialsusceptibilityinapparentlyhealthyandurinarytractinfected-240701045021-f89bd9ae-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The uroculturome indicates the profile of culturable microbes inhabiting the urinary tract, and it is often required to do a urine culture to find an effective antimicrobial to treat UTIs. This study targeted to understand the profile of culturable pathogens in the urine of apparently healthy (128) and humans with clinical UTIs (161). In urine samples from UTI cases, microbial counts were 1.2104 賊 6.02103 colony-forming units (cfu)/ mL, while in urine samples from apparently healthy humans, the average count was 3.33賊 1.34103 cfu/ mL. In eight samples (six from UTI cases and two from apparently healthy people) of urine, Candida (C. albicans 3, C. catenulata 1, C. krusei 1, C. tropicalis 1, C. parapsiplosis 1, C. gulliermondii 1) and Rhizopus species (1) were detected. Candida krusei was detected only in a single urine sample from a healthy person and C. albicans was detected both in urine of healthy and clinical UTI cases. Fungal strains were always detected with one or more types of bacteria. Gram-positive bacteria were more commonly (OR, 1.98; CI99, 1.01-3.87) detected in urine samples of apparently healthy humans, and Gram -ve bacteria (OR, 2.74; CI99, 1.44-5.23) in urines of UTI cases. From urine samples of 161 UTI cases, a total of 90 different types of microbes were detected and, 73 samples had only a single type of bacteria. In contrast, 49, 29, 3, 4, 1, and 2 samples had 2, 3, 4, 5, 6 and 7 types of bacteria, respectively. The most common bacteria detected in urine of UTI cases was Escherichia coli detected in 52 samples, in 20 cases as the single type of bacteria, other 34 types of bacteria were detected in pure form in 53 cases. From 128 urine samples of apparently healthy people, 88 types of microbes were detected either singly or in association with others, from 64 urine samples only a single type of bacteria was detected while 34, 13, 3, 11, 2 and 1 samples yielded 2, 3, 4, 5, 6 and seven types of microbes, respectively. In the urine of apparently healthy humans too, E. coli was the most common bacteria, detected in pure culture from 10 samples followed by Staphylococcus haemolyticus (9), S. intermedius (5), and S. aureus (5), and similar types of bacteria also dominated in cases of mixed occurrence, E. coli was detected in 26, S. aureus in 22 and S. haemolyticus in 19 urine samples, respectively. Gram +ve bacteria isolated from urine samples&#39; irrespective of health status were more often (p, &lt;0.01) resistant than Gram -ve bacteria to ajowan oil, holy basil oil, cinnamaldehyde, and cinnamon oil, but more susceptible to sandalwood oil (p, &lt;0.01). However, for antibiotics, Gram +ve were more often susceptible than Gram -ve bacteria to cephalosporins, doxycycline, and nitrofurantoin. The study concludes that to understand the role of good and bad bacteria in the urinary tract microbiome more targeted studies are needed to discern the isolates at the pathotype level.
A comparative study on uroculturome antimicrobial susceptibility in apparently healthy and urinary tract infected humans.pptx from Bhoj Raj Singh
]]>
515 0 https://cdn.slidesharecdn.com/ss_thumbnails/acomparativestudyonuroculturomeantimicrobialsusceptibilityinapparentlyhealthyandurinarytractinfected-240701045021-f89bd9ae-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Issues in Veterinary Disease Diagnosis.pptx /singh_br1762/issues-in-veterinary-disease-diagnosispptx issuesinveterinarydiseasediagnosis-230925154317-c8f51a6f
Diagnosis of a disease or a problem is the first step towards solution/ treatment/ control/ prevention. Diagnosis is successfully. important to determine Prevalence (True prevalence, apparent prevalence) and Incidence of the disease to estimate the disease burden so that prevention and control measures can be planned and implemented. However, in few years with the invasion of pharmaco-politics in disease control the term got vitiated. ]]>

Diagnosis of a disease or a problem is the first step towards solution/ treatment/ control/ prevention. Diagnosis is successfully. important to determine Prevalence (True prevalence, apparent prevalence) and Incidence of the disease to estimate the disease burden so that prevention and control measures can be planned and implemented. However, in few years with the invasion of pharmaco-politics in disease control the term got vitiated. ]]>
Mon, 25 Sep 2023 15:43:17 GMT /singh_br1762/issues-in-veterinary-disease-diagnosispptx singh_br1762@slideshare.net(singh_br1762) Issues in Veterinary Disease Diagnosis.pptx singh_br1762 Diagnosis of a disease or a problem is the first step towards solution/ treatment/ control/ prevention. Diagnosis is successfully. important to determine Prevalence (True prevalence, apparent prevalence) and Incidence of the disease to estimate the disease burden so that prevention and control measures can be planned and implemented. However, in few years with the invasion of pharmaco-politics in disease control the term got vitiated. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/issuesinveterinarydiseasediagnosis-230925154317-c8f51a6f-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Diagnosis of a disease or a problem is the first step towards solution/ treatment/ control/ prevention. Diagnosis is successfully. important to determine Prevalence (True prevalence, apparent prevalence) and Incidence of the disease to estimate the disease burden so that prevention and control measures can be planned and implemented. However, in few years with the invasion of pharmaco-politics in disease control the term got vitiated.
Issues in Veterinary Disease Diagnosis.pptx from Bhoj Raj Singh
]]>
136 0 https://cdn.slidesharecdn.com/ss_thumbnails/issuesinveterinarydiseasediagnosis-230925154317-c8f51a6f-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Epidemiological Approaches for Evaluation of diagnostic tests.pptx /slideshow/epidemiological-approaches-for-evaluation-of-diagnostic-testspptx/260175018 epidemiologicalapproachesforevaluationofdiagnostictests-230825121712-13266a73
Diagnosis of a disease or a problem is the first step towards solution/ treatment. Clinical Diagnosis or Provisional Diagnosis is the first step in diagnosis and is done after a physical examination of the patient by a clinician. Clinical diagnosis may or may not be true and to reach Final diagnosis Laboratory Investigations using gross and microscopic pathological observations and determining the disease indicators are required. The diagnostic tests may be Non-dichotomous Diagnostic Tests (when continuous values are given by the test in a range starting from sub-normal to above-normal range) and Dichotomous Diagnostic Tests (when results are given either plus or minus, disease or no-disease). To make non- Dichotomous diagnostic test a Dichotomous one you need to establish the cut-off values based on reference values or Gold Standard test readings or with the use of Receiver operator characteristic (ROC) curves, Precision-Recall Curves, Likelihood Ratios, etc., and finally establishing statistical agreement (using Kappa values, Level of Agreement, 2 Statistics) between the true diagnosis and laboratory diagnosis. Thereafter, the Accuracy, Precision, Bias, Sensitivity, Specificity, Positive Predictive value, and Negative Predictive value, of a diagnostic test are established for use in clinical practice. Diagnostic tests are also used to determine Prevalence (True prevalence, apparent prevalence) and Incidence of the disease to estimate the disease burden so that control measures can be implemented. There are several Phases in the development and use of a diagnostic assay starting from conceptualization of the diagnostic test, development and evaluation to determine flaws in diagnostic test use and Interpretation influencers. This presentation mainly deals with the epidemiological evaluation procedures for diagnostic tests.]]>

Diagnosis of a disease or a problem is the first step towards solution/ treatment. Clinical Diagnosis or Provisional Diagnosis is the first step in diagnosis and is done after a physical examination of the patient by a clinician. Clinical diagnosis may or may not be true and to reach Final diagnosis Laboratory Investigations using gross and microscopic pathological observations and determining the disease indicators are required. The diagnostic tests may be Non-dichotomous Diagnostic Tests (when continuous values are given by the test in a range starting from sub-normal to above-normal range) and Dichotomous Diagnostic Tests (when results are given either plus or minus, disease or no-disease). To make non- Dichotomous diagnostic test a Dichotomous one you need to establish the cut-off values based on reference values or Gold Standard test readings or with the use of Receiver operator characteristic (ROC) curves, Precision-Recall Curves, Likelihood Ratios, etc., and finally establishing statistical agreement (using Kappa values, Level of Agreement, 2 Statistics) between the true diagnosis and laboratory diagnosis. Thereafter, the Accuracy, Precision, Bias, Sensitivity, Specificity, Positive Predictive value, and Negative Predictive value, of a diagnostic test are established for use in clinical practice. Diagnostic tests are also used to determine Prevalence (True prevalence, apparent prevalence) and Incidence of the disease to estimate the disease burden so that control measures can be implemented. There are several Phases in the development and use of a diagnostic assay starting from conceptualization of the diagnostic test, development and evaluation to determine flaws in diagnostic test use and Interpretation influencers. This presentation mainly deals with the epidemiological evaluation procedures for diagnostic tests.]]>
Fri, 25 Aug 2023 12:17:12 GMT /slideshow/epidemiological-approaches-for-evaluation-of-diagnostic-testspptx/260175018 singh_br1762@slideshare.net(singh_br1762) Epidemiological Approaches for Evaluation of diagnostic tests.pptx singh_br1762 Diagnosis of a disease or a problem is the first step towards solution/ treatment. Clinical Diagnosis or Provisional Diagnosis is the first step in diagnosis and is done after a physical examination of the patient by a clinician. Clinical diagnosis may or may not be true and to reach Final diagnosis Laboratory Investigations using gross and microscopic pathological observations and determining the disease indicators are required. The diagnostic tests may be Non-dichotomous Diagnostic Tests (when continuous values are given by the test in a range starting from sub-normal to above-normal range) and Dichotomous Diagnostic Tests (when results are given either plus or minus, disease or no-disease). To make non- Dichotomous diagnostic test a Dichotomous one you need to establish the cut-off values based on reference values or Gold Standard test readings or with the use of Receiver operator characteristic (ROC) curves, Precision-Recall Curves, Likelihood Ratios, etc., and finally establishing statistical agreement (using Kappa values, Level of Agreement, 2 Statistics) between the true diagnosis and laboratory diagnosis. Thereafter, the Accuracy, Precision, Bias, Sensitivity, Specificity, Positive Predictive value, and Negative Predictive value, of a diagnostic test are established for use in clinical practice. Diagnostic tests are also used to determine Prevalence (True prevalence, apparent prevalence) and Incidence of the disease to estimate the disease burden so that control measures can be implemented. There are several Phases in the development and use of a diagnostic assay starting from conceptualization of the diagnostic test, development and evaluation to determine flaws in diagnostic test use and Interpretation influencers. This presentation mainly deals with the epidemiological evaluation procedures for diagnostic tests. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/epidemiologicalapproachesforevaluationofdiagnostictests-230825121712-13266a73-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Diagnosis of a disease or a problem is the first step towards solution/ treatment. Clinical Diagnosis or Provisional Diagnosis is the first step in diagnosis and is done after a physical examination of the patient by a clinician. Clinical diagnosis may or may not be true and to reach Final diagnosis Laboratory Investigations using gross and microscopic pathological observations and determining the disease indicators are required. The diagnostic tests may be Non-dichotomous Diagnostic Tests (when continuous values are given by the test in a range starting from sub-normal to above-normal range) and Dichotomous Diagnostic Tests (when results are given either plus or minus, disease or no-disease). To make non- Dichotomous diagnostic test a Dichotomous one you need to establish the cut-off values based on reference values or Gold Standard test readings or with the use of Receiver operator characteristic (ROC) curves, Precision-Recall Curves, Likelihood Ratios, etc., and finally establishing statistical agreement (using Kappa values, Level of Agreement, 2 Statistics) between the true diagnosis and laboratory diagnosis. Thereafter, the Accuracy, Precision, Bias, Sensitivity, Specificity, Positive Predictive value, and Negative Predictive value, of a diagnostic test are established for use in clinical practice. Diagnostic tests are also used to determine Prevalence (True prevalence, apparent prevalence) and Incidence of the disease to estimate the disease burden so that control measures can be implemented. There are several Phases in the development and use of a diagnostic assay starting from conceptualization of the diagnostic test, development and evaluation to determine flaws in diagnostic test use and Interpretation influencers. This presentation mainly deals with the epidemiological evaluation procedures for diagnostic tests.
Epidemiological Approaches for Evaluation of diagnostic tests.pptx from Bhoj Raj Singh
]]>
710 0 https://cdn.slidesharecdn.com/ss_thumbnails/epidemiologicalapproachesforevaluationofdiagnostictests-230825121712-13266a73-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and relevant rules.pptx /slideshow/types-of-trials-in-medicine-vaccine-efficacy-or-effectiveness-trials-and-relevant-rulespptx/259725685 typesoftrialsinmedicinevaccineefficacyoreffectivenesstrialsandrelevantrules-230808111451-b9272214
The importance of learning about medicines and vaccines efficacy or effectiveness trials is not only necessary to those who are developing, producing or marketing these pharmaceutical products but to the users also because: The Emergency approval of Covid-19 vaccines and many other medicines in last few years has created so much fuss to understand the reality. The lesson learnt from Covid-19 vaccine(s) by vaccine production, marketing, vaccination and finally the revenue earned by vaccine developers and producers, and political gain by politicians, is proving deleterious to the society as several vaccine(s), useless or scarcely proven safe and useful, are going to infest and some have already infested the market (the health industry). So reading this presentation may be useful to you so that you may question the authorities if any is engaged in bluffing you. The presentation talks briefly about Prevention trials, Screening trials, Treatment trials, Feasibility studies, Pilot studies, Phases in clinical trial, Multi-arm multi-stage (MAMS) trials, Global Clinical Trials, Vaccine efficacy, Vaccine safety, Emergency Use Authorization (EUA), Serious Adverse Events (SAE), SEA rules, The Vaccine Adverse Event Reporting System (VAERS), Vaccine Safety Datalink (VSD), The Advisory Committee on Immunization Practices (ACIP), Clinical Immunization Safety Assessment (CISA), CDSCO Rules Governing Clinical Trials, Schedule Y, The Ethics Committee, Empowered Committee on Animal Health, Tracking Vaccine Quality, Pre-clinical and Clinical data, Proof of Concept, Biological License Application (BLA) and Clinical hold. ]]>

The importance of learning about medicines and vaccines efficacy or effectiveness trials is not only necessary to those who are developing, producing or marketing these pharmaceutical products but to the users also because: The Emergency approval of Covid-19 vaccines and many other medicines in last few years has created so much fuss to understand the reality. The lesson learnt from Covid-19 vaccine(s) by vaccine production, marketing, vaccination and finally the revenue earned by vaccine developers and producers, and political gain by politicians, is proving deleterious to the society as several vaccine(s), useless or scarcely proven safe and useful, are going to infest and some have already infested the market (the health industry). So reading this presentation may be useful to you so that you may question the authorities if any is engaged in bluffing you. The presentation talks briefly about Prevention trials, Screening trials, Treatment trials, Feasibility studies, Pilot studies, Phases in clinical trial, Multi-arm multi-stage (MAMS) trials, Global Clinical Trials, Vaccine efficacy, Vaccine safety, Emergency Use Authorization (EUA), Serious Adverse Events (SAE), SEA rules, The Vaccine Adverse Event Reporting System (VAERS), Vaccine Safety Datalink (VSD), The Advisory Committee on Immunization Practices (ACIP), Clinical Immunization Safety Assessment (CISA), CDSCO Rules Governing Clinical Trials, Schedule Y, The Ethics Committee, Empowered Committee on Animal Health, Tracking Vaccine Quality, Pre-clinical and Clinical data, Proof of Concept, Biological License Application (BLA) and Clinical hold. ]]>
Tue, 08 Aug 2023 11:14:50 GMT /slideshow/types-of-trials-in-medicine-vaccine-efficacy-or-effectiveness-trials-and-relevant-rulespptx/259725685 singh_br1762@slideshare.net(singh_br1762) Types of Trials in Medicine, vaccine efficacy or effectiveness trials and relevant rules.pptx singh_br1762 The importance of learning about medicines and vaccines efficacy or effectiveness trials is not only necessary to those who are developing, producing or marketing these pharmaceutical products but to the users also because: The Emergency approval of Covid-19 vaccines and many other medicines in last few years has created so much fuss to understand the reality. The lesson learnt from Covid-19 vaccine(s) by vaccine production, marketing, vaccination and finally the revenue earned by vaccine developers and producers, and political gain by politicians, is proving deleterious to the society as several vaccine(s), useless or scarcely proven safe and useful, are going to infest and some have already infested the market (the health industry). So reading this presentation may be useful to you so that you may question the authorities if any is engaged in bluffing you. The presentation talks briefly about Prevention trials, Screening trials, Treatment trials, Feasibility studies, Pilot studies, Phases in clinical trial, Multi-arm multi-stage (MAMS) trials, Global Clinical Trials, Vaccine efficacy, Vaccine safety, Emergency Use Authorization (EUA), Serious Adverse Events (SAE), SEA rules, The Vaccine Adverse Event Reporting System (VAERS), Vaccine Safety Datalink (VSD), The Advisory Committee on Immunization Practices (ACIP), Clinical Immunization Safety Assessment (CISA), CDSCO Rules Governing Clinical Trials, Schedule Y, The Ethics Committee, Empowered Committee on Animal Health, Tracking Vaccine Quality, Pre-clinical and Clinical data, Proof of Concept, Biological License Application (BLA) and Clinical hold. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/typesoftrialsinmedicinevaccineefficacyoreffectivenesstrialsandrelevantrules-230808111451-b9272214-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The importance of learning about medicines and vaccines efficacy or effectiveness trials is not only necessary to those who are developing, producing or marketing these pharmaceutical products but to the users also because: The Emergency approval of Covid-19 vaccines and many other medicines in last few years has created so much fuss to understand the reality. The lesson learnt from Covid-19 vaccine(s) by vaccine production, marketing, vaccination and finally the revenue earned by vaccine developers and producers, and political gain by politicians, is proving deleterious to the society as several vaccine(s), useless or scarcely proven safe and useful, are going to infest and some have already infested the market (the health industry). So reading this presentation may be useful to you so that you may question the authorities if any is engaged in bluffing you. The presentation talks briefly about Prevention trials, Screening trials, Treatment trials, Feasibility studies, Pilot studies, Phases in clinical trial, Multi-arm multi-stage (MAMS) trials, Global Clinical Trials, Vaccine efficacy, Vaccine safety, Emergency Use Authorization (EUA), Serious Adverse Events (SAE), SEA rules, The Vaccine Adverse Event Reporting System (VAERS), Vaccine Safety Datalink (VSD), The Advisory Committee on Immunization Practices (ACIP), Clinical Immunization Safety Assessment (CISA), CDSCO Rules Governing Clinical Trials, Schedule Y, The Ethics Committee, Empowered Committee on Animal Health, Tracking Vaccine Quality, Pre-clinical and Clinical data, Proof of Concept, Biological License Application (BLA) and Clinical hold.
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and relevant rules.pptx from Bhoj Raj Singh
]]>
490 0 https://cdn.slidesharecdn.com/ss_thumbnails/typesoftrialsinmedicinevaccineefficacyoreffectivenesstrialsandrelevantrules-230808111451-b9272214-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes and Genotypes.pptx /slideshow/detection-and-characterization-of-pathotypes-serotypes-biotypes-phenotypes-and-genotypespptx/259544063 detectionandcharacterizationofpathotypesserotypesbiotypesphenotypesandgenotypes-230801060348-327d29c6
This presentation of my lecture, to Epidemiology students, briefs about different methods for differentiating or finding similarities among isolates of pathogens required establishing causal associations in epidemiological disease diagnosis.]]>

This presentation of my lecture, to Epidemiology students, briefs about different methods for differentiating or finding similarities among isolates of pathogens required establishing causal associations in epidemiological disease diagnosis.]]>
Tue, 01 Aug 2023 06:03:47 GMT /slideshow/detection-and-characterization-of-pathotypes-serotypes-biotypes-phenotypes-and-genotypespptx/259544063 singh_br1762@slideshare.net(singh_br1762) Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes and Genotypes.pptx singh_br1762 This presentation of my lecture, to Epidemiology students, briefs about different methods for differentiating or finding similarities among isolates of pathogens required establishing causal associations in epidemiological disease diagnosis. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/detectionandcharacterizationofpathotypesserotypesbiotypesphenotypesandgenotypes-230801060348-327d29c6-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This presentation of my lecture, to Epidemiology students, briefs about different methods for differentiating or finding similarities among isolates of pathogens required establishing causal associations in epidemiological disease diagnosis.
Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes and Genotypes.pptx from Bhoj Raj Singh
]]>
806 0 https://cdn.slidesharecdn.com/ss_thumbnails/detectionandcharacterizationofpathotypesserotypesbiotypesphenotypesandgenotypes-230801060348-327d29c6-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Epidemiology of antigenic, genetic and biological diversity amongst pathogens associated with disease outbreaks.pptx /slideshow/epidemiology-of-antigenic-genetic-and-biological-diversity-amongst-pathogens-associated-with-disease-outbreakspptx/259455375 epidemiologyofantigenicgeneticandbiologicaldiversityamongstpathogensassociatedwithdiseaseoutbreaks-230727064402-51ed0404
This presentation briefly describes the Antigenic, genetic and biological diversity amongst pathogens, and their origin and emergence. It also discusses with their association with different forms associated with a disease/ outbreak. The presentation also enlists diversity in strains causing some common diseases of livestock in India. ]]>

This presentation briefly describes the Antigenic, genetic and biological diversity amongst pathogens, and their origin and emergence. It also discusses with their association with different forms associated with a disease/ outbreak. The presentation also enlists diversity in strains causing some common diseases of livestock in India. ]]>
Thu, 27 Jul 2023 06:44:02 GMT /slideshow/epidemiology-of-antigenic-genetic-and-biological-diversity-amongst-pathogens-associated-with-disease-outbreakspptx/259455375 singh_br1762@slideshare.net(singh_br1762) Epidemiology of antigenic, genetic and biological diversity amongst pathogens associated with disease outbreaks.pptx singh_br1762 This presentation briefly describes the Antigenic, genetic and biological diversity amongst pathogens, and their origin and emergence. It also discusses with their association with different forms associated with a disease/ outbreak. The presentation also enlists diversity in strains causing some common diseases of livestock in India. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/epidemiologyofantigenicgeneticandbiologicaldiversityamongstpathogensassociatedwithdiseaseoutbreaks-230727064402-51ed0404-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This presentation briefly describes the Antigenic, genetic and biological diversity amongst pathogens, and their origin and emergence. It also discusses with their association with different forms associated with a disease/ outbreak. The presentation also enlists diversity in strains causing some common diseases of livestock in India.
Epidemiology of antigenic, genetic and biological diversity amongst pathogens associated with disease outbreaks.pptx from Bhoj Raj Singh
]]>
386 0 https://cdn.slidesharecdn.com/ss_thumbnails/epidemiologyofantigenicgeneticandbiologicaldiversityamongstpathogensassociatedwithdiseaseoutbreaks-230727064402-51ed0404-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA & DISA vaccines).pptx /slideshow/differentiation-of-field-isolates-wild-from-vaccine-strains-marker-diva-disa-vaccinespptx/259269151 differentiationoffieldisolateswildfromvaccinestrainsmarkerdivadisavaccines-230718042013-198271fb
Nowadays vaccination is often reported as the cause of disease outbreaks. To ward off this misconception (vaccines are made to save the masses not to risk their lives)or to understand vaccination failures, it is necessary to understand the difference between a field strain causing the disease and a vaccine strain having attenuated virulence. This presentation talks about DIVA and DISA vaccines too.]]>

Nowadays vaccination is often reported as the cause of disease outbreaks. To ward off this misconception (vaccines are made to save the masses not to risk their lives)or to understand vaccination failures, it is necessary to understand the difference between a field strain causing the disease and a vaccine strain having attenuated virulence. This presentation talks about DIVA and DISA vaccines too.]]>
Tue, 18 Jul 2023 04:20:13 GMT /slideshow/differentiation-of-field-isolates-wild-from-vaccine-strains-marker-diva-disa-vaccinespptx/259269151 singh_br1762@slideshare.net(singh_br1762) Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA & DISA vaccines).pptx singh_br1762 Nowadays vaccination is often reported as the cause of disease outbreaks. To ward off this misconception (vaccines are made to save the masses not to risk their lives)or to understand vaccination failures, it is necessary to understand the difference between a field strain causing the disease and a vaccine strain having attenuated virulence. This presentation talks about DIVA and DISA vaccines too. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/differentiationoffieldisolateswildfromvaccinestrainsmarkerdivadisavaccines-230718042013-198271fb-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Nowadays vaccination is often reported as the cause of disease outbreaks. To ward off this misconception (vaccines are made to save the masses not to risk their lives)or to understand vaccination failures, it is necessary to understand the difference between a field strain causing the disease and a vaccine strain having attenuated virulence. This presentation talks about DIVA and DISA vaccines too.
Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA & DISA vaccines).pptx from Bhoj Raj Singh
]]>
456 0 https://cdn.slidesharecdn.com/ss_thumbnails/differentiationoffieldisolateswildfromvaccinestrainsmarkerdivadisavaccines-230718042013-198271fb-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Lumpy skin disease (LSD) Globally and in India.pptx /singh_br1762/lumpy-skin-disease-lsd-globally-and-in-indiapptx lumpyskindiseaselsdgloballyandinindia-230715075632-55c424aa
LSD has emerged as a dairy industry devastating disease in India in the last four years. First noticed in Orrisa and is now present all over India. Recurring outbreaks are now noticed in Rajasthan, Uttarakhand and other states indicating that the disease is becoming endemic in India.]]>

LSD has emerged as a dairy industry devastating disease in India in the last four years. First noticed in Orrisa and is now present all over India. Recurring outbreaks are now noticed in Rajasthan, Uttarakhand and other states indicating that the disease is becoming endemic in India.]]>
Sat, 15 Jul 2023 07:56:32 GMT /singh_br1762/lumpy-skin-disease-lsd-globally-and-in-indiapptx singh_br1762@slideshare.net(singh_br1762) Lumpy skin disease (LSD) Globally and in India.pptx singh_br1762 LSD has emerged as a dairy industry devastating disease in India in the last four years. First noticed in Orrisa and is now present all over India. Recurring outbreaks are now noticed in Rajasthan, Uttarakhand and other states indicating that the disease is becoming endemic in India. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/lumpyskindiseaselsdgloballyandinindia-230715075632-55c424aa-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> LSD has emerged as a dairy industry devastating disease in India in the last four years. First noticed in Orrisa and is now present all over India. Recurring outbreaks are now noticed in Rajasthan, Uttarakhand and other states indicating that the disease is becoming endemic in India.
Lumpy skin disease (LSD) Globally and in India.pptx from Bhoj Raj Singh
]]>
2420 0 https://cdn.slidesharecdn.com/ss_thumbnails/lumpyskindiseaselsdgloballyandinindia-230715075632-55c424aa-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Molecular determinants of pathogenicity and virulence among pathogens.pptx /slideshow/molecular-determinants-of-pathogenicity-and-virulence-among-pathogenspptx/259157851 moleculardeterminantsofpathogenicityandvirulenceamongpathogens-230712101500-6a181c54
The presentation discusses the pathogenicity and virulence of pathogens, their determinants and their interaction with the host. It talks briefly about pathogenicity, virulence, adhesions, invasions, toxins, disease, pathogenesis, pathogenicity islands (PAIs), intracellular, extracellular, bacteria, virus, fungi, prion, metazoan worms, protozoa, tuberculosis, E. coli, Salmonella, Yersinia, Mycobacterium, cytotoxins, enterotoxins, exotoxins, neurotoxins, endotoxins, in-silico, in-Vitro, in-vivo, immunohistology, haemagglutinins, spike proteins, integrins, and phagolysosomes.]]>

The presentation discusses the pathogenicity and virulence of pathogens, their determinants and their interaction with the host. It talks briefly about pathogenicity, virulence, adhesions, invasions, toxins, disease, pathogenesis, pathogenicity islands (PAIs), intracellular, extracellular, bacteria, virus, fungi, prion, metazoan worms, protozoa, tuberculosis, E. coli, Salmonella, Yersinia, Mycobacterium, cytotoxins, enterotoxins, exotoxins, neurotoxins, endotoxins, in-silico, in-Vitro, in-vivo, immunohistology, haemagglutinins, spike proteins, integrins, and phagolysosomes.]]>
Wed, 12 Jul 2023 10:14:59 GMT /slideshow/molecular-determinants-of-pathogenicity-and-virulence-among-pathogenspptx/259157851 singh_br1762@slideshare.net(singh_br1762) Molecular determinants of pathogenicity and virulence among pathogens.pptx singh_br1762 The presentation discusses the pathogenicity and virulence of pathogens, their determinants and their interaction with the host. It talks briefly about pathogenicity, virulence, adhesions, invasions, toxins, disease, pathogenesis, pathogenicity islands (PAIs), intracellular, extracellular, bacteria, virus, fungi, prion, metazoan worms, protozoa, tuberculosis, E. coli, Salmonella, Yersinia, Mycobacterium, cytotoxins, enterotoxins, exotoxins, neurotoxins, endotoxins, in-silico, in-Vitro, in-vivo, immunohistology, haemagglutinins, spike proteins, integrins, and phagolysosomes. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/moleculardeterminantsofpathogenicityandvirulenceamongpathogens-230712101500-6a181c54-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The presentation discusses the pathogenicity and virulence of pathogens, their determinants and their interaction with the host. It talks briefly about pathogenicity, virulence, adhesions, invasions, toxins, disease, pathogenesis, pathogenicity islands (PAIs), intracellular, extracellular, bacteria, virus, fungi, prion, metazoan worms, protozoa, tuberculosis, E. coli, Salmonella, Yersinia, Mycobacterium, cytotoxins, enterotoxins, exotoxins, neurotoxins, endotoxins, in-silico, in-Vitro, in-vivo, immunohistology, haemagglutinins, spike proteins, integrins, and phagolysosomes.
Molecular determinants of pathogenicity and virulence among pathogens.pptx from Bhoj Raj Singh
]]>
1388 0 https://cdn.slidesharecdn.com/ss_thumbnails/moleculardeterminantsofpathogenicityandvirulenceamongpathogens-230712101500-6a181c54-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Molecular epidemiology and Disease causation.pptx /singh_br1762/molecular-epidemiology-and-disease-causationpptx molecularepidemiologyanddiseasecausation-230707052757-96770f0a
This short presentation describes molecular epidemiology, differentiate it from genetic epidemiology, and also deals with ascertaining the cause of disease.]]>

This short presentation describes molecular epidemiology, differentiate it from genetic epidemiology, and also deals with ascertaining the cause of disease.]]>
Fri, 07 Jul 2023 05:27:57 GMT /singh_br1762/molecular-epidemiology-and-disease-causationpptx singh_br1762@slideshare.net(singh_br1762) Molecular epidemiology and Disease causation.pptx singh_br1762 This short presentation describes molecular epidemiology, differentiate it from genetic epidemiology, and also deals with ascertaining the cause of disease. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/molecularepidemiologyanddiseasecausation-230707052757-96770f0a-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This short presentation describes molecular epidemiology, differentiate it from genetic epidemiology, and also deals with ascertaining the cause of disease.
Molecular epidemiology and Disease causation.pptx from Bhoj Raj Singh
]]>
872 0 https://cdn.slidesharecdn.com/ss_thumbnails/molecularepidemiologyanddiseasecausation-230707052757-96770f0a-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the last five years.pptx /slideshow/my-research-proposals-to-porotect-holy-cow-rejected-by-the-icarivri-in-the-last-five-yearspptx/258284968 myresearchproposalstoporotectholycowrejectedbytheicar-ivriinthelastfiveyears-230607061502-043bd32e
The presentation relates to my three research proposals, aimed at Protection of Holy cow, rejected at ICAR-ICAR-Indian Veterinary Research Institute, Izatnagar-243 122, India, in last five years Clinical evaluation of newly advocated therapies for brucellosis in cattle and buffaloes. Duration: September 2019 to August 2021 A cross-sectional survey of Holy Cow Infectious Problems in Gaushalas (Gaushalas are protective shelters for stray cows in India). Duration: September 2022-August 2024 Explorative study on Epidemiological determinants associated with a drastic reduction in Milk Production of Dairy Animals with reference to communicable diseases. Duration: September 2022-August 2024 ]]>

The presentation relates to my three research proposals, aimed at Protection of Holy cow, rejected at ICAR-ICAR-Indian Veterinary Research Institute, Izatnagar-243 122, India, in last five years Clinical evaluation of newly advocated therapies for brucellosis in cattle and buffaloes. Duration: September 2019 to August 2021 A cross-sectional survey of Holy Cow Infectious Problems in Gaushalas (Gaushalas are protective shelters for stray cows in India). Duration: September 2022-August 2024 Explorative study on Epidemiological determinants associated with a drastic reduction in Milk Production of Dairy Animals with reference to communicable diseases. Duration: September 2022-August 2024 ]]>
Wed, 07 Jun 2023 06:15:02 GMT /slideshow/my-research-proposals-to-porotect-holy-cow-rejected-by-the-icarivri-in-the-last-five-yearspptx/258284968 singh_br1762@slideshare.net(singh_br1762) My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the last five years.pptx singh_br1762 The presentation relates to my three research proposals, aimed at Protection of Holy cow, rejected at ICAR-ICAR-Indian Veterinary Research Institute, Izatnagar-243 122, India, in last five years Clinical evaluation of newly advocated therapies for brucellosis in cattle and buffaloes. Duration: September 2019 to August 2021 A cross-sectional survey of Holy Cow Infectious Problems in Gaushalas (Gaushalas are protective shelters for stray cows in India). Duration: September 2022-August 2024 Explorative study on Epidemiological determinants associated with a drastic reduction in Milk Production of Dairy Animals with reference to communicable diseases. Duration: September 2022-August 2024 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/myresearchproposalstoporotectholycowrejectedbytheicar-ivriinthelastfiveyears-230607061502-043bd32e-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The presentation relates to my three research proposals, aimed at Protection of Holy cow, rejected at ICAR-ICAR-Indian Veterinary Research Institute, Izatnagar-243 122, India, in last five years Clinical evaluation of newly advocated therapies for brucellosis in cattle and buffaloes. Duration: September 2019 to August 2021 A cross-sectional survey of Holy Cow Infectious Problems in Gaushalas (Gaushalas are protective shelters for stray cows in India). Duration: September 2022-August 2024 Explorative study on Epidemiological determinants associated with a drastic reduction in Milk Production of Dairy Animals with reference to communicable diseases. Duration: September 2022-August 2024
My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the last five years.pptx from Bhoj Raj Singh
]]>
242 0 https://cdn.slidesharecdn.com/ss_thumbnails/myresearchproposalstoporotectholycowrejectedbytheicar-ivriinthelastfiveyears-230607061502-043bd32e-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary Science Doyens and administrators.pptx /singh_br1762/animal-disease-control-and-antimicrobial-resistancea-message-to-veterinary-science-doyens-and-administratorspptx-258232709 animaldiseasecontrolandantimicrobialresistance-amessagetoveterinarysciencedoyensandadministrators-230604060636-54489aec
This presentation is for Introspection by all authorities before criticizing Veterinarians for an increase in AMR & to Doyens of Veterinary Science sitting mum when Vets are criticized! To realize that DAHD and State Animal/ Livestock Departments are: Fake data masters! A realization to Doyens of Veterinary Science that they are: Spineless when their voice is the most needed! Dont understand epidemiology to the least and make minimal attempts to improve Epidemiological understanding in veterinarians! The real negative thinkers! Suffering from an inferiority complex! Real killers of the holy cow! Interested to develop the best vet doctors but creating butchers! Real anti-nationals! They talk of one health without understanding it! Much more!!!]]>

This presentation is for Introspection by all authorities before criticizing Veterinarians for an increase in AMR & to Doyens of Veterinary Science sitting mum when Vets are criticized! To realize that DAHD and State Animal/ Livestock Departments are: Fake data masters! A realization to Doyens of Veterinary Science that they are: Spineless when their voice is the most needed! Dont understand epidemiology to the least and make minimal attempts to improve Epidemiological understanding in veterinarians! The real negative thinkers! Suffering from an inferiority complex! Real killers of the holy cow! Interested to develop the best vet doctors but creating butchers! Real anti-nationals! They talk of one health without understanding it! Much more!!!]]>
Sun, 04 Jun 2023 06:06:36 GMT /singh_br1762/animal-disease-control-and-antimicrobial-resistancea-message-to-veterinary-science-doyens-and-administratorspptx-258232709 singh_br1762@slideshare.net(singh_br1762) Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary Science Doyens and administrators.pptx singh_br1762 This presentation is for Introspection by all authorities before criticizing Veterinarians for an increase in AMR & to Doyens of Veterinary Science sitting mum when Vets are criticized! To realize that DAHD and State Animal/ Livestock Departments are: Fake data masters! A realization to Doyens of Veterinary Science that they are: Spineless when their voice is the most needed! Dont understand epidemiology to the least and make minimal attempts to improve Epidemiological understanding in veterinarians! The real negative thinkers! Suffering from an inferiority complex! Real killers of the holy cow! Interested to develop the best vet doctors but creating butchers! Real anti-nationals! They talk of one health without understanding it! Much more!!! <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/animaldiseasecontrolandantimicrobialresistance-amessagetoveterinarysciencedoyensandadministrators-230604060636-54489aec-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This presentation is for Introspection by all authorities before criticizing Veterinarians for an increase in AMR &amp; to Doyens of Veterinary Science sitting mum when Vets are criticized! To realize that DAHD and State Animal/ Livestock Departments are: Fake data masters! A realization to Doyens of Veterinary Science that they are: Spineless when their voice is the most needed! Dont understand epidemiology to the least and make minimal attempts to improve Epidemiological understanding in veterinarians! The real negative thinkers! Suffering from an inferiority complex! Real killers of the holy cow! Interested to develop the best vet doctors but creating butchers! Real anti-nationals! They talk of one health without understanding it! Much more!!!
Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary Science Doyens and administrators.pptx from Bhoj Raj Singh
]]>
43 0 https://cdn.slidesharecdn.com/ss_thumbnails/animaldiseasecontrolandantimicrobialresistance-amessagetoveterinarysciencedoyensandadministrators-230604060636-54489aec-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Causes of Disease and Preserving Health in Different systems of Medicine.pptx /slideshow/causes-of-disease-and-preserving-health-in-different-systems-of-medicinepptx/258128926 causesofdiseaseandpreservinghealthindifferentsystemsofmedicine-230530112004-5d59ec61
This presentation deals with concepts of disease causation and methods used for the alleviation of those causes to ensure health. It has briefed the causes of diseases according to Ayurvedic medicine, Unani medicine, Siddham medicine, Naturopathy, Homeopathy, Chinese medicine, Touch therapy- Reiki, Mantra therapy, and Allopathy. It also summarizes the treatments and practices in different systems of medicine. DOI: 10.13140/RG.2.2.30883.22569]]>

This presentation deals with concepts of disease causation and methods used for the alleviation of those causes to ensure health. It has briefed the causes of diseases according to Ayurvedic medicine, Unani medicine, Siddham medicine, Naturopathy, Homeopathy, Chinese medicine, Touch therapy- Reiki, Mantra therapy, and Allopathy. It also summarizes the treatments and practices in different systems of medicine. DOI: 10.13140/RG.2.2.30883.22569]]>
Tue, 30 May 2023 11:20:04 GMT /slideshow/causes-of-disease-and-preserving-health-in-different-systems-of-medicinepptx/258128926 singh_br1762@slideshare.net(singh_br1762) Causes of Disease and Preserving Health in Different systems of Medicine.pptx singh_br1762 This presentation deals with concepts of disease causation and methods used for the alleviation of those causes to ensure health. It has briefed the causes of diseases according to Ayurvedic medicine, Unani medicine, Siddham medicine, Naturopathy, Homeopathy, Chinese medicine, Touch therapy- Reiki, Mantra therapy, and Allopathy. It also summarizes the treatments and practices in different systems of medicine. DOI: 10.13140/RG.2.2.30883.22569 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/causesofdiseaseandpreservinghealthindifferentsystemsofmedicine-230530112004-5d59ec61-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This presentation deals with concepts of disease causation and methods used for the alleviation of those causes to ensure health. It has briefed the causes of diseases according to Ayurvedic medicine, Unani medicine, Siddham medicine, Naturopathy, Homeopathy, Chinese medicine, Touch therapy- Reiki, Mantra therapy, and Allopathy. It also summarizes the treatments and practices in different systems of medicine. DOI: 10.13140/RG.2.2.30883.22569
Causes of Disease and Preserving Health in Different systems of Medicine.pptx from Bhoj Raj Singh
]]>
1130 0 https://cdn.slidesharecdn.com/ss_thumbnails/causesofdiseaseandpreservinghealthindifferentsystemsofmedicine-230530112004-5d59ec61-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
AMR challenges in human from animal foods- Facts and Myths.pptx /slideshow/amr-challenges-in-human-from-animal-foods-facts-and-mythspptx/256997125 amrchallengesinhumanfromanimalfoods-factsandmyths-230330103010-18257061
This presentation talks about MR: A public health threat, a silent pandemic. Infections caused by Antimicrobial-drug-resistant (AMR) pathogens caused >1.27 million deaths worldwide in 2019 (low level or no surveillance) and increasing year after year which may be > million in coming decades. Covid-19 caused ~6.8 million deaths in >3 years but now the pandemic is ending but the AMR pandemic has no timeline for its ending. Many deaths are also attributed to AMR pathogens. More antibiotic use (irrespective of the sector) = More AMR. This presentation also talks about ways and means to mitigate the AMR pandemic. 1. Stopping the blame game. All are equally responsible for the emergence of AMR, the share of developed and educated communities is much more than poor and un-educated communities. 2. Working together: On-Line Real-Time AST Data Sharing Platform for different diagnostic and research laboratories doing AST routinely. 3. Implementing not only antibiotic veterinary and medical stewardship but antimicrobial production and distribution stewardship too. 4. Educating for Environmental health not only human, plant, and animal health. 5. AMR's solution is not in searching for alternatives to antibiotics but in establishing environmental harmony. 6. More emphasis on AMR epidemiology than on AMR microbiology and pharmacology. 7. Development of understanding that bacteria and other microbes are more essential for life on earth than the human race. Microbes can live without humans, but humans cant without microbes. Global-Health is of prime importance than economic growth/ greediness. ]]>

This presentation talks about MR: A public health threat, a silent pandemic. Infections caused by Antimicrobial-drug-resistant (AMR) pathogens caused >1.27 million deaths worldwide in 2019 (low level or no surveillance) and increasing year after year which may be > million in coming decades. Covid-19 caused ~6.8 million deaths in >3 years but now the pandemic is ending but the AMR pandemic has no timeline for its ending. Many deaths are also attributed to AMR pathogens. More antibiotic use (irrespective of the sector) = More AMR. This presentation also talks about ways and means to mitigate the AMR pandemic. 1. Stopping the blame game. All are equally responsible for the emergence of AMR, the share of developed and educated communities is much more than poor and un-educated communities. 2. Working together: On-Line Real-Time AST Data Sharing Platform for different diagnostic and research laboratories doing AST routinely. 3. Implementing not only antibiotic veterinary and medical stewardship but antimicrobial production and distribution stewardship too. 4. Educating for Environmental health not only human, plant, and animal health. 5. AMR's solution is not in searching for alternatives to antibiotics but in establishing environmental harmony. 6. More emphasis on AMR epidemiology than on AMR microbiology and pharmacology. 7. Development of understanding that bacteria and other microbes are more essential for life on earth than the human race. Microbes can live without humans, but humans cant without microbes. Global-Health is of prime importance than economic growth/ greediness. ]]>
Thu, 30 Mar 2023 10:30:10 GMT /slideshow/amr-challenges-in-human-from-animal-foods-facts-and-mythspptx/256997125 singh_br1762@slideshare.net(singh_br1762) AMR challenges in human from animal foods- Facts and Myths.pptx singh_br1762 This presentation talks about MR: A public health threat, a silent pandemic. Infections caused by Antimicrobial-drug-resistant (AMR) pathogens caused >1.27 million deaths worldwide in 2019 (low level or no surveillance) and increasing year after year which may be > million in coming decades. Covid-19 caused ~6.8 million deaths in >3 years but now the pandemic is ending but the AMR pandemic has no timeline for its ending. Many deaths are also attributed to AMR pathogens. More antibiotic use (irrespective of the sector) = More AMR. This presentation also talks about ways and means to mitigate the AMR pandemic. 1. Stopping the blame game. All are equally responsible for the emergence of AMR, the share of developed and educated communities is much more than poor and un-educated communities. 2. Working together: On-Line Real-Time AST Data Sharing Platform for different diagnostic and research laboratories doing AST routinely. 3. Implementing not only antibiotic veterinary and medical stewardship but antimicrobial production and distribution stewardship too. 4. Educating for Environmental health not only human, plant, and animal health. 5. AMR's solution is not in searching for alternatives to antibiotics but in establishing environmental harmony. 6. More emphasis on AMR epidemiology than on AMR microbiology and pharmacology. 7. Development of understanding that bacteria and other microbes are more essential for life on earth than the human race. Microbes can live without humans, but humans cant without microbes. Global-Health is of prime importance than economic growth/ greediness. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/amrchallengesinhumanfromanimalfoods-factsandmyths-230330103010-18257061-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This presentation talks about MR: A public health threat, a silent pandemic. Infections caused by Antimicrobial-drug-resistant (AMR) pathogens caused &gt;1.27 million deaths worldwide in 2019 (low level or no surveillance) and increasing year after year which may be &gt; million in coming decades. Covid-19 caused ~6.8 million deaths in &gt;3 years but now the pandemic is ending but the AMR pandemic has no timeline for its ending. Many deaths are also attributed to AMR pathogens. More antibiotic use (irrespective of the sector) = More AMR. This presentation also talks about ways and means to mitigate the AMR pandemic. 1. Stopping the blame game. All are equally responsible for the emergence of AMR, the share of developed and educated communities is much more than poor and un-educated communities. 2. Working together: On-Line Real-Time AST Data Sharing Platform for different diagnostic and research laboratories doing AST routinely. 3. Implementing not only antibiotic veterinary and medical stewardship but antimicrobial production and distribution stewardship too. 4. Educating for Environmental health not only human, plant, and animal health. 5. AMR&#39;s solution is not in searching for alternatives to antibiotics but in establishing environmental harmony. 6. More emphasis on AMR epidemiology than on AMR microbiology and pharmacology. 7. Development of understanding that bacteria and other microbes are more essential for life on earth than the human race. Microbes can live without humans, but humans cant without microbes. Global-Health is of prime importance than economic growth/ greediness.
AMR challenges in human from animal foods- Facts and Myths.pptx from Bhoj Raj Singh
]]>
871 0 https://cdn.slidesharecdn.com/ss_thumbnails/amrchallengesinhumanfromanimalfoods-factsandmyths-230330103010-18257061-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Herbal Antimicrobials to Counter AMR.pptx /slideshow/herbal-antimicrobials-to-counter-amrpptx/255873172 herbalantimicrobialstocounteramr-230215160955-f1f63e14
Herbal antimicrobials are considered as an important alternative to antibiotic and probable tools to mitigate emerging antimicrobial-drug-resistance (AMR). However, it is difficult to accept that microbes may not adapt to herbal antimicrobials as rapidly as to antibiotics. This is now well documented that herbal antimicrobial resistance is also common among common pathogenic microbes and genes are now known to encode herbal drug-resistance too. This lecture gives description how resistance to conventional antimicrobials impacts susceptibility of microbes for herbal antimicrobials. Lecture Scheduled on 21st February 2023, In: Antimicrobial Resistance (AMR) in Foodborne pathogens sponsored under the ICAR-NAHEP-CAAST project by the MAFSU, Mumbai Veterinary College, at the Division of Veterinary Public Health, ICAR-IVRI from 20thFebruary to 25thFebruary, 2023. ]]>

Herbal antimicrobials are considered as an important alternative to antibiotic and probable tools to mitigate emerging antimicrobial-drug-resistance (AMR). However, it is difficult to accept that microbes may not adapt to herbal antimicrobials as rapidly as to antibiotics. This is now well documented that herbal antimicrobial resistance is also common among common pathogenic microbes and genes are now known to encode herbal drug-resistance too. This lecture gives description how resistance to conventional antimicrobials impacts susceptibility of microbes for herbal antimicrobials. Lecture Scheduled on 21st February 2023, In: Antimicrobial Resistance (AMR) in Foodborne pathogens sponsored under the ICAR-NAHEP-CAAST project by the MAFSU, Mumbai Veterinary College, at the Division of Veterinary Public Health, ICAR-IVRI from 20thFebruary to 25thFebruary, 2023. ]]>
Wed, 15 Feb 2023 16:09:55 GMT /slideshow/herbal-antimicrobials-to-counter-amrpptx/255873172 singh_br1762@slideshare.net(singh_br1762) Herbal Antimicrobials to Counter AMR.pptx singh_br1762 Herbal antimicrobials are considered as an important alternative to antibiotic and probable tools to mitigate emerging antimicrobial-drug-resistance (AMR). However, it is difficult to accept that microbes may not adapt to herbal antimicrobials as rapidly as to antibiotics. This is now well documented that herbal antimicrobial resistance is also common among common pathogenic microbes and genes are now known to encode herbal drug-resistance too. This lecture gives description how resistance to conventional antimicrobials impacts susceptibility of microbes for herbal antimicrobials. Lecture Scheduled on 21st February 2023, In: Antimicrobial Resistance (AMR) in Foodborne pathogens sponsored under the ICAR-NAHEP-CAAST project by the MAFSU, Mumbai Veterinary College, at the Division of Veterinary Public Health, ICAR-IVRI from 20thFebruary to 25thFebruary, 2023. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/herbalantimicrobialstocounteramr-230215160955-f1f63e14-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Herbal antimicrobials are considered as an important alternative to antibiotic and probable tools to mitigate emerging antimicrobial-drug-resistance (AMR). However, it is difficult to accept that microbes may not adapt to herbal antimicrobials as rapidly as to antibiotics. This is now well documented that herbal antimicrobial resistance is also common among common pathogenic microbes and genes are now known to encode herbal drug-resistance too. This lecture gives description how resistance to conventional antimicrobials impacts susceptibility of microbes for herbal antimicrobials. Lecture Scheduled on 21st February 2023, In: Antimicrobial Resistance (AMR) in Foodborne pathogens sponsored under the ICAR-NAHEP-CAAST project by the MAFSU, Mumbai Veterinary College, at the Division of Veterinary Public Health, ICAR-IVRI from 20thFebruary to 25thFebruary, 2023.
Herbal Antimicrobials to Counter AMR.pptx from Bhoj Raj Singh
]]>
396 0 https://cdn.slidesharecdn.com/ss_thumbnails/herbalantimicrobialstocounteramr-230215160955-f1f63e14-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from clinical samples of animals and associated environment /slideshow/epidemiological-characterisation-of-burkholderia-cepacia-complex-bcc-from-clinical-samples-of-animals-and-associated-environment/252861293 prethesis27-220907023058-40b7ee3a
The presentation is extracted from the thesis talking about 1. The presence of Bcc organisms in the clinical infections of animals. 2. Ultrasound gels as a potential source of pathogens, especially Bcc. 3. Multidrug resistance in BCCs. 4. Lack of regulatory guidelines in Indian Pharmacopeia as existing in USP. ]]>

The presentation is extracted from the thesis talking about 1. The presence of Bcc organisms in the clinical infections of animals. 2. Ultrasound gels as a potential source of pathogens, especially Bcc. 3. Multidrug resistance in BCCs. 4. Lack of regulatory guidelines in Indian Pharmacopeia as existing in USP. ]]>
Wed, 07 Sep 2022 02:30:58 GMT /slideshow/epidemiological-characterisation-of-burkholderia-cepacia-complex-bcc-from-clinical-samples-of-animals-and-associated-environment/252861293 singh_br1762@slideshare.net(singh_br1762) Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from clinical samples of animals and associated environment singh_br1762 The presentation is extracted from the thesis talking about 1. The presence of Bcc organisms in the clinical infections of animals. 2. Ultrasound gels as a potential source of pathogens, especially Bcc. 3. Multidrug resistance in BCCs. 4. Lack of regulatory guidelines in Indian Pharmacopeia as existing in USP. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/prethesis27-220907023058-40b7ee3a-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The presentation is extracted from the thesis talking about 1. The presence of Bcc organisms in the clinical infections of animals. 2. Ultrasound gels as a potential source of pathogens, especially Bcc. 3. Multidrug resistance in BCCs. 4. Lack of regulatory guidelines in Indian Pharmacopeia as existing in USP.
Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from clinical samples of animals and associated environment from Bhoj Raj Singh
]]>
1351 0 https://cdn.slidesharecdn.com/ss_thumbnails/prethesis27-220907023058-40b7ee3a-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Veterinary Vaccines.pptx /slideshow/veterinary-vaccinespptx/251622728 veterinaryvaccines-220420055855
There are hundreds of diseases of livestock and pet animals that can be printed through properly used quality vaccines. This presentation summarises different types of vaccines used by veterinarians to control/ prevent diseases. The presentation enlists the vaccine-preventable diseases of pets and livestock, and also the different vaccines used.]]>

There are hundreds of diseases of livestock and pet animals that can be printed through properly used quality vaccines. This presentation summarises different types of vaccines used by veterinarians to control/ prevent diseases. The presentation enlists the vaccine-preventable diseases of pets and livestock, and also the different vaccines used.]]>
Wed, 20 Apr 2022 05:58:55 GMT /slideshow/veterinary-vaccinespptx/251622728 singh_br1762@slideshare.net(singh_br1762) Veterinary Vaccines.pptx singh_br1762 There are hundreds of diseases of livestock and pet animals that can be printed through properly used quality vaccines. This presentation summarises different types of vaccines used by veterinarians to control/ prevent diseases. The presentation enlists the vaccine-preventable diseases of pets and livestock, and also the different vaccines used. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/veterinaryvaccines-220420055855-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> There are hundreds of diseases of livestock and pet animals that can be printed through properly used quality vaccines. This presentation summarises different types of vaccines used by veterinarians to control/ prevent diseases. The presentation enlists the vaccine-preventable diseases of pets and livestock, and also the different vaccines used.
Veterinary Vaccines.pptx from Bhoj Raj Singh
]]>
9013 0 https://cdn.slidesharecdn.com/ss_thumbnails/veterinaryvaccines-220420055855-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
Major flaws in Animal Disease Control Leading to Partial Success or Failure.pptx /slideshow/major-flaws-in-animal-disease-control-leading-to-partial-success-or-failurepptx/251622622 majorflawsinanimaldiseasecontrolleadingtopartialsuccessorfailure-220420054258
This presentation summarises major problems of Animal Disease Control Programs ongoing in India. India is a hyperendemic country for many animal diseases and zoonotic diseases. Every year billions of rupees are spent on disease control, surveillance, monitoring, and vaccination against vaccine-preventable diseases. However, due to the failure of most animal disease control programs for one or other reasons India directly losses about 20 and 25 thousand crores annually due to endemicity of FMD & brucellosis, respectively. The presentation identifies problems at different levels of different ongoing disease control programs in India. The non-availability of authentic disease data and flaws in vaccine quality control are the biggest problems. ]]>

This presentation summarises major problems of Animal Disease Control Programs ongoing in India. India is a hyperendemic country for many animal diseases and zoonotic diseases. Every year billions of rupees are spent on disease control, surveillance, monitoring, and vaccination against vaccine-preventable diseases. However, due to the failure of most animal disease control programs for one or other reasons India directly losses about 20 and 25 thousand crores annually due to endemicity of FMD & brucellosis, respectively. The presentation identifies problems at different levels of different ongoing disease control programs in India. The non-availability of authentic disease data and flaws in vaccine quality control are the biggest problems. ]]>
Wed, 20 Apr 2022 05:42:58 GMT /slideshow/major-flaws-in-animal-disease-control-leading-to-partial-success-or-failurepptx/251622622 singh_br1762@slideshare.net(singh_br1762) Major flaws in Animal Disease Control Leading to Partial Success or Failure.pptx singh_br1762 This presentation summarises major problems of Animal Disease Control Programs ongoing in India. India is a hyperendemic country for many animal diseases and zoonotic diseases. Every year billions of rupees are spent on disease control, surveillance, monitoring, and vaccination against vaccine-preventable diseases. However, due to the failure of most animal disease control programs for one or other reasons India directly losses about 20 and 25 thousand crores annually due to endemicity of FMD & brucellosis, respectively. The presentation identifies problems at different levels of different ongoing disease control programs in India. The non-availability of authentic disease data and flaws in vaccine quality control are the biggest problems. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/majorflawsinanimaldiseasecontrolleadingtopartialsuccessorfailure-220420054258-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This presentation summarises major problems of Animal Disease Control Programs ongoing in India. India is a hyperendemic country for many animal diseases and zoonotic diseases. Every year billions of rupees are spent on disease control, surveillance, monitoring, and vaccination against vaccine-preventable diseases. However, due to the failure of most animal disease control programs for one or other reasons India directly losses about 20 and 25 thousand crores annually due to endemicity of FMD &amp; brucellosis, respectively. The presentation identifies problems at different levels of different ongoing disease control programs in India. The non-availability of authentic disease data and flaws in vaccine quality control are the biggest problems.
Major flaws in Animal Disease Control Leading to Partial Success or Failure.pptx from Bhoj Raj Singh
]]>
591 0 https://cdn.slidesharecdn.com/ss_thumbnails/majorflawsinanimaldiseasecontrolleadingtopartialsuccessorfailure-220420054258-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
https://cdn.slidesharecdn.com/profile-photo-singh_br1762-48x48.jpg?cb=1750455077 I am blogging at http://azad-azadindia.blogspot.com/ See my >40 presentations on slideshare at: http://www.slideshare.net/singh_br1762 Publications at: https://www.researchgate.net/profile/Bhoj_Singh/stats Developed First Oral Salmonella vaccine for animals (equids) Developed Toxoid vaccine for control of Salmonellosis in poultry birds andKlebsiellosis in fur animals. Developed kit for diagnostics of parvovirus infection in dogs, salmonellosis and klebsiellosis in animals. Developed synthetic milk detection strip able to detect synthetic milk ingredients within 30 s using a drop of milk, reaction read with naked eyes. Established maternal transfer of microbiome in lizards. Explored vag... https://cdn.slidesharecdn.com/ss_thumbnails/yogaforforhealth-250620001734-24c66535-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/yoga-postures-to-practice-for-holistic-physical-mental-and-cognitive-well-being/280781630 Yoga Postures to Pract... https://cdn.slidesharecdn.com/ss_thumbnails/classificationofmicrobes-250220184536-029c5e5b-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/classification-of-microbes-purposes-and-uses/275863977 Classification of Micr... https://cdn.slidesharecdn.com/ss_thumbnails/acomparativestudyonuroculturomeantimicrobialsusceptibilityinapparentlyhealthyandurinarytractinfected-240701045021-f89bd9ae-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/a-comparative-study-on-uroculturome-antimicrobial-susceptibility-in-apparently-healthy-and-urinary-tract-infected-humans-pptx/269987018 A comparative study on...